Most recently, Areteia Therapeutics raised $425.0M in its Early Stage VC (Series A1) (Feb 2024).
- ·The complete investor list: 11 names
- ·Watch Areteia Therapeutics: the Monday email on marks, rounds and moves
Areteia Therapeutics round by round
2 roundsHow much has Areteia Therapeutics raised?
Areteia Therapeutics has raised $425 million across 2 recorded rounds since 2022. The largest was a $425 million Series A1 in Feb 2024.
Areteia Therapeutics has filed 2 Form Ds with the SEC since 2024, most recently in Feb 2025 ($360 million sold to 16 investors).
Areteia Therapeutics investors
11 investors are on record for Areteia Therapeutics, including Viking Global Investors, GV, ARCH Venture Partners and Marshall Wace. By type, the record holds 3 venture capital firms, 2 hedge funds and 1 asset manager. The Series A1 in Feb 2024 drew 9 investors.
11 investors have backed Areteia Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Areteia Therapeutics
- How much has Areteia Therapeutics raised?
- Areteia Therapeutics has raised $425.0M in total across 2 recorded funding rounds.
- When was Areteia Therapeutics's last funding round?
- Areteia Therapeutics's most recent recorded round was Early Stage VC (Series A1) in Feb 2024, raising $425.0M.